These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21733911)

  • 41. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
    Tuñón J; Fernández-Fernández B; Carda R; Pello AM; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Hernández-González I; Mahíllo-Fernández I; López-Bescós L; Egido J
    Diabetes Metab Res Rev; 2016 Oct; 32(7):685-693. PubMed ID: 26888181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease.
    Masai H; Joki N; Sugi K; Moroi M
    Atherosclerosis; 2013 Jan; 226(1):228-33. PubMed ID: 23137826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
    Okamoto Y; Fujita S; Morita H; Kizawa S; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
    Heart Vessels; 2016 Jan; 31(1):66-73. PubMed ID: 25223536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha Klotho and Fibroblast Growth Factor-23 Among Alcoholics.
    Quintero-Platt G; González-Reimers E; Rodríguez-Gaspar M; Martín-González C; Pérez-Hernández O; Romero-Acevedo L; Espelosín-Ortega E; Vega-Prieto MJ; Santolaria-Fernández F
    Alcohol Alcohol; 2017 Sep; 52(5):542-549. PubMed ID: 28651327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease.
    Wang R; Yi X; Li X; Jiang X
    Int J Clin Exp Pathol; 2015; 8(11):14901-8. PubMed ID: 26823820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.
    Humalda JK; Riphagen IJ; Assa S; Hummel YM; Westerhuis R; Vervloet MG; Voors AA; Navis G; Franssen CF; de Borst MH;
    Nephrol Dial Transplant; 2016 Sep; 31(9):1494-501. PubMed ID: 26602863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery.
    Hofer F; Hammer A; Pailer U; Koller L; Kazem N; Steinacher E; Steinlechner B; Andreas M; Laufer G; Wojta J; Zelniker TA; Hengstenberg C; Niessner A; Sulzgruber P
    J Am Heart Assoc; 2023 Mar; 12(5):e027875. PubMed ID: 36802737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.
    Buiten MS; de Bie MK; Bouma-de Krijger A; van Dam B; Dekker FW; Jukema JW; Rabelink TJ; Rotmans JI
    BMC Nephrol; 2014 Dec; 15():197. PubMed ID: 25495997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
    JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients.
    Sharma S; Joseph J; Chonchol M; Kaufman JS; Cheung AK; Rafeq Z; Smits G; Kendrick J;
    Clin Nephrol; 2013 Nov; 80(5):313-21. PubMed ID: 23849306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of fibroblast growth factor-23 in the pathogenesis of atherosclerosis in peritoneal dialysis patients.
    Zeng Y; Feng S; Han OY; Shen HY; Jin DH; Shi YB
    Genet Mol Res; 2015 Jan; 14(1):719-29. PubMed ID: 25730009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy.
    Dogan B; Arikan IH; Guler D; Keles N; Isbilen B; Isman F; Oguz A
    Int Urol Nephrol; 2016 Mar; 48(3):399-407. PubMed ID: 26759325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis.
    von Jeinsen B; Sopova K; Palapies L; Leistner DM; Fichtlscherer S; Seeger FH; Honold J; Dimmeler S; Aßmus B; Zeiher AM; Keller T
    ESC Heart Fail; 2019 Jun; 6(3):536-544. PubMed ID: 30912310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased serum phosphate and adverse clinical outcomes: unraveling mechanisms of disease.
    Gutiérrez OM
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):224-8. PubMed ID: 21245761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphate and FGF-23.
    Jüppner H
    Kidney Int Suppl; 2011 Apr; 79(121):S24-7. PubMed ID: 21346724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGF-23 and cardiovascular disease: review of literature.
    Batra J; Buttar RS; Kaur P; Kreimerman J; Melamed ML
    Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):423-429. PubMed ID: 27652999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Fibroblast growth factor-23 (FGF-23). Part III. Relationship between FGF-23 serum concentration and cardio-vascular morbidity and mortality].
    Fedak D; Bigaj K; Sułowicz W
    Przegl Lek; 2011; 68(9):614-8. PubMed ID: 22335012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FGF-23 and cognitive performance in hemodialysis patients.
    Drew DA; Tighiouart H; Scott TM; Lou KV; Fan L; Shaffi K; Weiner DE; Sarnak MJ
    Hemodial Int; 2014 Jan; 18(1):78-86. PubMed ID: 24164913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased red blood cell distribution width might predict left ventricular hypertrophy in patients with atrial fibrillation.
    Yao HM; Wang XL; Peng X; Chen SY; Wan X; Zuo W; Gan X
    Medicine (Baltimore); 2020 Sep; 99(37):e22119. PubMed ID: 32925759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.
    Kanbay M; Wolf M; Selcoki Y; Solak Y; Ikizek M; Uysal S; Segall L; Armutcu F; Eryonucu B; Duranay M; Goldsmith D; Covic A
    Int Urol Nephrol; 2012 Aug; 44(4):1169-75. PubMed ID: 22130958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.